Capital Increase Renewal
Company Schedules Extraordinary Shareholders' Meeting for July 2026 to Renew Capital Authority
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a Belgian medical technology company focused on sleep apnea treatment, has called an Extraordinary Shareholders' Meeting for July 9, 2026, at 2:00 p.m. CET. GlobeNewswire reported the formal invitation was issued on June 19, 2026, after a first meeting on June 10 failed to reach the required attendance threshold.
The single item on the agenda is renewing the board's power to increase the company's share capital — a five-year authorization that gives Nyxoah flexibility to raise funds quickly without calling another shareholder vote each time. According to ADVFN, this second meeting can legally proceed regardless of how many shareholders show up.
First Meeting Failed, So July 9 Gets a Free Pass
Under Belgian company law, an extraordinary meeting normally needs at least 50% of all shares represented to vote on capital increases. The June 10 meeting did not hit that mark. Because this July 9 session is a second attempt, that 50% quorum rule is waived entirely — meaning even a small group of shareholders can decide the outcome, according to Market Screener.
However, the vote still needs a strong majority to pass. At least 75% of votes cast on the day must be in favor. Shareholders who want to participate must register their intent by July 3, 2026. Only those holding shares at midnight CET on June 25, 2026 — the official record date — are eligible to vote.
What a Five-Year Capital Authorization Actually Means
The board is asking shareholders to grant it the power to issue new shares for five years without holding a separate vote each time. This kind of permission is called "authorized capital" under Belgian law. It starts counting from the date the decision is published in Belgium's official legal gazette. Financial Content noted the authorization is equal to the company's current total share capital.
In practice, this means Nyxoah could potentially double its outstanding shares over five years. For existing investors, that raises dilution risk — more shares mean each existing share represents a smaller slice of the company. The upside is speed: Nyxoah can respond quickly to funding needs, whether for research, commercial expansion, or acquisitions, without the months-long delay of calling a new shareholder vote.
Video Conference Available but Not a Full Voting Tool
Nyxoah will set up a video conference so shareholders can watch the meeting from home. But the company was careful to draw a legal line: this does not count as an official "electronic communication tool" under Belgian law. That distinction matters. ADVFN explained that formal electronic voting tools require strict technical and security standards the company has chosen not to implement here.
As a result, shareholders who cannot travel to Mont-Saint-Guibert, Belgium, must cast their votes either by postal mail or by appointing a proxy — someone to vote on their behalf in person. The video stream is a viewing convenience, not an interactive voting channel. Check-in at the physical venue opens at 1:45 p.m. CET on July 9.
Nyxoah Has Used Capital Raises Before to Fund Growth
Nyxoah is not new to tapping capital markets. The company has previously used warrant exercises to raise small amounts — including roughly €34,000 in June 2025 and €10,000 in May 2025 — to fund development of its Genio® sleep apnea device. Those were small moves. The authorized capital renewal would give the board room to make much larger raises if needed.
If shareholders approve the resolution on July 9, investors should watch for the subsequent notice in Belgium's Official Gazette. That publication date — not the meeting date — is when the five-year clock officially starts ticking on the board's new capital-raising powers.
Sentiment
NeutralPublishers
4
Articles
4
Reach
4
